Marc David Benathen's Insider Trades & SAST Disclosures
Marc David Benathen's most recent trade in LifeMD Inc was a trade of 75,000 Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Marc David Benathen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 75,000 | 464,554 | - | 0 | Common Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 87,000 | 389,554 | - | 0 | Common Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 75,000 | 302,554 | - | 0 | Common Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jan 2023 | 200,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 125,000 | 202,554 | - | - | Common Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 25,000 | 0 | - | - | Restricted Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 25,000 | 77,554 | - | 0 | Common Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 25,000 | 227,554 | - | 0 | Common Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 25,000 | 25,000 | - | - | Restricted Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 75,000 | 75,000 | - | - | Restricted Stock Unit | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2022 | 25,000 | 52,554 | - | 0 | Common Stock | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2022 | 25,000 | 50,000 | - | - | Restricted Stock Unit | |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.09 per share. | 30 Nov 2021 | 7,831 | 27,554 | - | 4.1 | 32,029 | Common Stock, par value $0.01 |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.26 per share. | 18 Aug 2021 | 1,300 | 19,253 | - | 7.3 | 9,438 | Common Stock |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.23 per share. | 18 Aug 2021 | 1,297 | 17,953 | - | 7.2 | 9,377 | Common Stock |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.43 per share. | 18 Aug 2021 | 343 | 19,723 | - | 7.4 | 2,548 | Common Stock |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.30 per share. | 18 Aug 2021 | 64 | 19,317 | - | 7.3 | 467 | Common Stock |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.24 per share. | 18 Aug 2021 | 63 | 19,380 | - | 7.2 | 456 | Common Stock |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.93 per share. | 19 May 2021 | 1,099 | 16,339 | - | 8.9 | 9,818 | Common Stock |
| LifeMD Inc | Marc David Benathen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.81 per share. | 19 May 2021 | 317 | 16,656 | - | 8.8 | 2,792 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges